NOTHING LIKE A CLASS ACTION FOR SLATER & GORDON TO MOVE ON

NOTHING LIKE A CLASS ACTION FOR SLATER & GORDON TO MOVE ON

AFTER rankling shareholders with its own share price collapse late last year, listed legal group Slater & Gordon (ASX:SGH) has climbed back on the horse with plans to mount a class action of its own on behalf of Murray Goulburn investors.

Shares in Murray Goulburn slumped more than 40 per cent this week after the embattled milk supplier downgraded its FY16 profit forecast from $63 million to as low as $39 million.

It was the second downgrade by the company since it listed last year, with the company blaming lower dairy commodity prices and a slowdown in Chinese demand for infant formula.

The latest shock to investors led to the resignation this week of Murray Goulburn's CEO Gary Helou and CFO Brad Hingle.

Slater & Gordon, backed by litigation funder IMF Bentham, says it is investigating Murray Goulburn's profit guidance in its prospectus issued in July last year as a basis for the class action.

It says the potential class action will involve investors who bought units in Murray Goulburn's listed entity MG Unit Trust before April 27, including those who invested in the company's IPO in July last year.

Murray Goulburn had originally forecast a profit of $85.8 million for FY16, before downgrading that to $63 million on February 29, citing a downturn in dairy prices.

"On April 12, and again on April 18, Murray Goulburn confirmed that Chinese regulators were tightening regulations on imports of milk products into China, but denied that the anticipated regulatory changes would have a material impact on Murray Goulburn's business," says Slater & Gordon.

The legal firm is investigating whether Murray Goulburn misled investors with its initial prospectus forecast or with its downgraded profit forecast earlier this year. It also is investigating whether the company breached continuous disclosure obligations to investors.

"Our initial investigations have identified inconsistencies between Murray Goulburn's statements to the market regarding its likely profits in the 2016 financial year, and the factors that would affect its performance," says Slater & Gordon's senior class action lawyer Tim Finney.

"(Wednesday's) downgrade was of such a scale that it cannot be explained by the excuses that have so far been provided.

"We are investigating whether the true cause of Murray Goulburn's downgrade was an aggressively optimistic profit forecast, built into its product disclosure statement, that the company was simply never going to achieve."

Slater & Gordon's potential class action comes on the heels of the legal group enduring its own shareholder revolt late last year after it delivered a profit downgrade stemming from its trouble-plagued UK acquisition, Quindell.

Class action specialist Maurice Blackburn revealed it had received registrations from 'thousands of aggrieved shareholders' after Slater & Gordon's share price lost 90 per cent of its value over the past year.

In February, Slater & Gordon recorded a $958.3 million loss for the six months ending December last year, which included an $876.4 million impairment charge against goodwill and a $52.7 million impairment charge in the Australian business.

 

Get our daily business news

Sign up to our free email news updates.

 
Four time-saving tips for automating your investment portfolio
Partner Content
In today's fast-paced investment landscape, time is a valuable commodity. Fortunately, w...
Etoro
Advertisement

Related Stories

Nick Scali shares reach all-time high following UK expansion plans

Nick Scali shares reach all-time high following UK expansion plans

Nick Scali’s (ASX: NCK) plans to expand into the UK have...

Super Retail Group to face court over allegations of undisclosed exec relationship, bullying

Super Retail Group to face court over allegations of undisclosed exec relationship, bullying

The board of Super Retail Group (ASX: SUL) has announced today that...

Aussie-founded sleep device giant ResMed sees profit lift 29pc

Aussie-founded sleep device giant ResMed sees profit lift 29pc

Shareholders backing Australian-founded, California-based sleep med...

“Difficult decision”: Atlassian co-CEO Scott Farquhar to step down

“Difficult decision”: Atlassian co-CEO Scott Farquhar to step down

After 23 years as co-CEO of Sydney-headquartered software giant Atl...